Raheleh Tahmasvand
Department of Physiology and pharmacology, Pasteur Institute of Iran, Tehran, Iran.
[ 1 ] - Two Novel Compounds with Tri-aryl Structures as Effective Anti-Breast Cancer Candidates In-vivo
Prognosis of metastatic breast cancer is very poor which urges the necessity to develop novel potential drug candidates. We assessed two compounds with tri-aryl structures (A and B) for their potency to reduce primary breast tumor growth and lung metastasis in 4T1 mice model. MTT assay, 4T1 mammary mouse model and immunohistochemistry experiments were used in this study. In vitro results exhibi...
[ 2 ] - Two Novel Compounds with Tri-aryl Structures as Effective Anti-Breast Cancer Candidates In-vivo
Prognosis of metastatic breast cancer is very poor which urges the necessity to develop novel potential drug candidates. We assessed two compounds with tri-aryl structures (A and B) for their potency to reduce primary breast tumor growth and lung metastasis in 4T1 mice model. MTT assay, 4T1 mammary mouse model and immunohistochemistry experiments were used in this study. In vitro results exhibi...
Co-Authors